TAKEDA PHARMACEUTICAL CO LTD reported 1 transaction at XILIO THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 10/26/2021ACC: 0001395064-21-000216
10% Owner
Since Oct 2021
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
1.48M acquired · 1.48M disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+1.48M
Price / share
—
Trade value
—
% of position
New position
10/26/2021
0.00→1.48M
Total
Net shares
+1.48M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 10/26/2021 | C · Conversion | +1.48M | — | — | New position | 0.00 | 1.48M |
| Total | +1.48M | $0.00 | ||||||
Derivative Transactions2
Series B Preferred Stock
Indirect
Converts to
Common Stock
1.25M shares
Shares
−1.25M
Strike price
Held after
0.00
Exercisable
—
10/26/2021
Series C Preferred Stock
Indirect
Converts to
Common Stock
226.94K shares
Shares
−226.94K
Strike price
Held after
0.00
Exercisable
—
10/26/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series B Preferred Stock Indirect | Common Stock1.25M shares | 10/26/2021 | C · Conversion | −1.25M | — | 0.00 | |
| Series C Preferred Stock Indirect | Common Stock226.94K shares | 10/26/2021 | C · Conversion | −226.94K | — | 0.00 |